
Ezak Pharma Private Limited
About Ezak Pharma Private Limited
Data last updated:
Ezak Pharma Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 03 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2013PTC250207. Its GSTIN is 10AADCE3268L1ZR (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Guncha Tabasum and Furquan Ahmad Azad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. – A29/A 4th/F Abul Fazal Enclave Shaheen Bagh Near Thokar No 6, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.99 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net loss of ₹3.26 Lakh (net margin -36.3%) and EBITDA of -₹3.25 Lakh (EBITDA margin -36.1%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 146% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ezak Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH. No. – A29/A 4th/F Abul Fazal Enclave Shaheen Bagh Near Thokar No 6, Delhi, India – 110025
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Ezak Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ezak Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ezak Pharma Private Limited, buy the company report.
Financials of Ezak Pharma Private Limited
FY 2025 filings availableEzak Pharma Private Limited reported revenue of ₹8.99 Lakh (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 146% over five years, including 25% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -36.1% | ||||
| Net Profit Margin | -36.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ezak Pharma Private Limited, buy the company report.
Board of directors of Ezak Pharma Private Limited
Ezak Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Guncha Tabasum | Director | 03 Apr 2013 | 13 Years 7 Months | Current |
| Furquan Ahmad Azad Also directs: Alamkul Education Foundation | Director | 03 Apr 2013 | 13 Years 7 Months | Current |
Peer comparison
Ezak Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Phillford Health Care India (OPC) Private Limited | ₹9 Lakh (FY 2018) | -71.0% | Delhi, India | |||
| Medicas Curas Private Limited | ₹9 Lakh (FY 2020) | Samanpura, B V College, Bihar, India | ||||
| Luu Luu Homes Private Limited | ₹9 Lakh (FY 2025) | 50.0% | Chennai, Tamil Nadu, India | |||
| Basic Human Health Care Private Limited | ₹9 Lakh (FY 2023) | -51.0% | New Delhi, Delhi, India | |||
| Navicon Infotech Private Limited | ₹8.99 Lakh (FY 2018) | 25.0% | Patna, Bihar, India | |||
| Ezak Pharma Private Limitedthis company | ₹8.99 Lakh (FY 2025) | -₹3.26 Lakh | -36.3% | 25.0% | Delhi, India | |
| Gautam Budh Infrastructures Private Limited | ₹8.99 Lakh (FY 2018) | -44.0% | Delhi, India | |||
| Sree Pharma Solution Private Limited | ₹8.99 Lakh (FY 2025) | -12.0% | Kolkata, West Bengal, India | |||
| Bansen Agro Farmer Producer Company Limited | ₹8.99 Lakh (FY 2024) | 129.0% | Bansen, Rajasthan, India | |||
| Neha Plantation Private Limited | ₹8.99 Lakh (FY 2025) | -82.0% | Uttar Pradesh, India | |||
| Madurai Tara Traders Private Limited | ₹8.99 Lakh (FY 2024) | -89.0% | Kovilpatti, Tamil Nadu, India |
To see the full peer comparison of Ezak Pharma Private Limited, buy the company report.
Auditor
Ezak Pharma Private Limited is audited by SGJAIN&COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SGJAIN&COMPANY | FY 2017 | 027206N |
Shareholding
The shareholding of Ezak Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ezak Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ezak Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ezak Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ezak Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCE3268L1ZR | Bihar | Active | 29 Dec 2020 |
To see the full GST registrations and return filing status of Ezak Pharma Private Limited, buy the company report.
Recent activity
Ezak Pharma Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Furquan Ahmad Azad was appointed as Director on 03 Apr 2013.
Frequently asked questions
Ezak Pharma is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 03 April 2013 (13+ years old) and is registered under CIN U51397DL2013PTC250207.
Ezak Pharma has 2 current directors:
- Guncha Tabasum - Director
- Furquan Ahmad Azad - Director
The latest financial statements of Ezak Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ezak Pharma is 10AADCE3268L1ZR, registered in Bihar.
The CIN (Corporate Identification Number) of Ezak Pharma is U51397DL2013PTC250207. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ezak Pharma was incorporated on 03 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ezak Pharma by revenue are Phillford Health Care India (OPC) Private Limited, Medicas Curas Private Limited, Luu Luu Homes Private Limited, Basic Human Health Care Private Limited, Navicon Infotech Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Furquan Ahmad Azad was appointed as Director on 03 Apr 2013. Guncha Tabasum was appointed as Director on 03 Apr 2013.
The registered office of Ezak Pharma is at H. No. – A29A 4thF Abul Fazal Enclave Shaheen Bagh Near Thokar No 6, Delhi, India – 110025.
Ezak Pharma operates in the trading industry, in the other wholesale segment.
The compliance status of Ezak Pharma is compliant as of 27 July 2026. The company is actively filing with the Registrar of Companies.

